John Armitage Avantor, Inc. Transaction History

Egerton Capital (Uk) LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$8.27 - $19.24 $60.9 Million - $142 Million	-7,362,154 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.63 - $18.56 $100 Million - $137 Million	7,362,154 New	7,362,154 $134 Million
Q3 2019 Nov 13, 2019	SELL	$13.85 - $19.18 $60.8 Million - $84.2 Million	-4,387,416 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$14.5 - $19.09 $63.6 Million - $83.8 Million	4,387,416 New	4,387,416 $83.8 Million

557

655M

3.97M

Ticker AVTR
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 674,035,008
Market Cap $15.5B
Description
Avantor, Inc. provides products and services to customers in biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulate...

Get notified when there are updates to the investment portfolio of Egerton Capital (Uk) LLP, based on Form 13F filings with the SEC.

Stay updated on Egerton Capital (Uk) LLP and John Armitage with notifications on news.